PND40 BUDGET IMPACT ANALYSIS OF GALCANEZUMAB-GNLM FOR THE PREVENTIVE TREATMENT OF PATIENTS WITH CHRONIC AND EPISODIC MIGRAINE IN THE UNITED STATES

Saved in:
Bibliographic Details
Published inValue in health Vol. 22; p. S277
Main Authors Foster, S.A., Milev, S., Hoog, M., Mason, O., Sardesai, A., Hasan, A., Marrone, C.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.05.2019
Subjects
Internal Medicine
Public Health
Online AccessGet full text
ISSN1098-3015
1524-4733
DOI10.1016/j.jval.2019.04.1313

Cover